Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,174 | 160 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $674.69 | 26 | $0 (2024) |
| Alkermes, Inc. | $657.59 | 36 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $630.58 | 42 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $465.36 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $361.32 | 17 | $0 (2024) |
| ABBVIE INC. | $235.77 | 12 | $0 (2024) |
| ITI, Inc. | $49.36 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $37.93 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $22.35 | 1 | $0 (2024) |
| Indivior Inc. | $20.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,252 | 57 | Teva Pharmaceuticals USA, Inc. ($526.55) |
| 2023 | $1,207 | 71 | Otsuka America Pharmaceutical, Inc. ($367.49) |
| 2022 | $677.12 | 29 | Alkermes, Inc. ($205.11) |
| 2021 | $37.93 | 3 | Sunovion Pharmaceuticals Inc. ($37.93) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: Central Nervous System | ||||||
| 07/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Neuropsychiatry | ||||||
| 07/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: CNS | ||||||
| 07/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Central Nervous System | ||||||
| 07/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: CNS | ||||||
| 07/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: Central Nervous System | ||||||
| 06/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Central Nervous System | ||||||
| 06/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: Neurology | ||||||
| 06/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: CNS | ||||||
| 06/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Central Nervous System | ||||||
| 05/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Central Nervous System | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Neuroscience | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 259 | 761 | $98,775 | $39,326 |
| 2022 | 2 | 277 | 362 | $53,340 | $25,912 |
| 2021 | 2 | 77 | 145 | $15,950 | $5,535 |
| 2020 | 3 | 129 | 420 | $47,830 | $17,579 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 688 | $86,000 | $34,399 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 73 | $12,775 | $4,927 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 172 | $29,590 | $14,080 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 190 | $23,750 | $11,831 | 49.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 87 | $8,700 | $2,875 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 58 | $7,250 | $2,660 | 36.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 190 | $23,750 | $9,798 | 41.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 218 | $21,800 | $7,018 | 32.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 12 | 12 | $2,280 | $763.03 | 33.5% |
About John Talbot, RNAP
John Talbot, RNAP is a Psychiatric/Mental Health healthcare provider based in Northampton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326066515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Talbot, RNAP has received a total of $3,174 in payments from pharmaceutical and medical device companies, with $1,252 received in 2024. These payments were reported across 160 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($3,174).
As a Medicare-enrolled provider, Talbot has provided services to 742 Medicare beneficiaries, totaling 1,688 services with total Medicare billing of $88,352. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Clinical Nurse Specialist, Psychiatric/Mental Health
- Location Northampton, MA
- Active Since 07/17/2006
- Last Updated 07/22/2015
- Taxonomy Code 163WP0808X
- Entity Type Individual
- NPI Number 1326066515
Products in Payments
- ARISTADA (Drug) $619.93
- INGREZZA (Drug) $465.36
- REXULTI (Drug) $434.57
- Austedo XR (Drug) $369.50
- SPRAVATO (Drug) $273.53
- VRAYLAR (Drug) $235.77
- ABILIFY MAINTENA (Drug) $179.47
- UZEDY (Drug) $157.05
- AUSTEDO (Drug) $148.14
- INVEGA SUSTENNA (Drug) $87.79
- CAPLYTA (Drug) $49.36
- LATUDA (Drug) $37.93
- COBENFY (Drug) $22.35
- PERSERIS (Drug) $20.02
- Vivitrol (Drug) $19.82
- Azstarys (Drug) $18.74
- VIVITROL (Drug) $17.84
- ABILIFY ASIMTUFII (Drug) $16.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Northampton
Samantha Capistrant
Psychiatric/Mental Health — Payments: $142.70
Mrs. Kelly Buckley, Np, NP
Psychiatric/Mental Health — Payments: $36.68
Audrey Hall, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $29.70
Mrs. Karen Coccoluto, Aprn Bc Pc, APRN BC PC
Psychiatric/Mental Health
Ms. Robyn Miller, Cns, CNS
Psychiatric/Mental Health
Corrina Riley
Psychiatric/Mental Health